Join Now

Category Archives: BioUtah News

Governor Cox Visits BD

By admin | Published June 6, 2024

SANDY, UTAH, June 6, 2024—Today Governor Spencer Cox visited BD’s Sandy campus to meet with company executives and participate in a town hall meeting with BD employees. Cox’s visit began by listening to a brief presentation about BD’s local and global impact to both patients and the Utah economy by Jeff Stevens, BD’s vice president/general […]

| Comments Off on Governor Cox Visits BD

Utah Gathers at BIO International 2024 in San Diego

By admin | Published June 6, 2024

BioUtah and its Utah consortium made their mark this week at the BIO International Conference, hosting a Utah Pavillion to promote the state’s fast-growing life sciences industry. The conference, held in San Diego, CA. drew appproximately 19,000 attendees. The Utah delegation included BioUtah, Utah companies, the Governor’s Office of Economic Development, the Unversity of Utah’s […]

| Comments Off on Utah Gathers at BIO International 2024 in San Diego

A former legislator and a biotech executive join Tribune’s board of directors

By Natalie Themm | Published June 6, 2024

Rebecca Chavez-Houck and Chris Gibson bring unique perspectives to board that oversees the nonprofit news outlet, they said.

| Tagged | Comments Off on A former legislator and a biotech executive join Tribune’s board of directors

Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development

By Natalie Themm | Published June 6, 2024

Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development

| Tagged | Comments Off on Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development

ELITechGroup achieves a new CE-IVDR Certification

By Natalie Themm | Published June 6, 2024

ELITechGroup continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories

| Tagged | Comments Off on ELITechGroup achieves a new CE-IVDR Certification

Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

By Natalie Themm | Published June 6, 2024

The Thermo Scientific™ Stellar™ mass spectrometer combines speed and sensitivity to advance precision medicine.

| Tagged | Comments Off on Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

Denali Therapeutics Announces FDA Has Selected DNL126 for MPS IIIA for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies

By Natalie Themm | Published June 6, 2024

START is a pilot program newly launched jointly by the FDA CDER and CBER divisions to further accelerate the development of novel drug and biological products for rare diseases

| Tagged | Comments Off on Denali Therapeutics Announces FDA Has Selected DNL126 for MPS IIIA for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies

FIVE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR FEMALE AND SMALL ANNULUS PATIENTS WITH EDWARDS TAVR

By Natalie Themm | Published June 6, 2024

FIVE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR FEMALE AND SMALL ANNULUS PATIENTS WITH EDWARDS TAVR

| Tagged | Comments Off on FIVE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR FEMALE AND SMALL ANNULUS PATIENTS WITH EDWARDS TAVR

TD Cowen 8th Annual Future of the Consumer Conference 2024

By Natalie Themm | Published June 6, 2024

Owlet presented at the TD Cowen 8th Annual Future of the Consumer Conference 2024.

| Tagged | Comments Off on TD Cowen 8th Annual Future of the Consumer Conference 2024

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

By Natalie Themm | Published June 6, 2024

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

| Tagged | Comments Off on Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

Tellus Wellness Taps Nomi Health as Its Partner to Pay Providers

By Natalie Themm | Published June 6, 2024

Nomi’s payment infrastructure shortens Tellus’ payment cycle from as much as 30-60 days to just one day.

| Tagged | Comments Off on Tellus Wellness Taps Nomi Health as Its Partner to Pay Providers

Edwards Lifesciences to Sell Critical Care to BD

By Natalie Themm | Published June 6, 2024

Agreement strengthens Edwards’ strategy to advance structural heart innovation.

| Tagged , | Comments Off on Edwards Lifesciences to Sell Critical Care to BD

A Special Thanks To Our Legacy and Platinum Elite Members